← REGULATORY CHANGES
FEDERAL REGISTER · NOTICEAugust 14, 2026NOTICE — NO LEGAL EFFECT

Container Closure Systems for Human Drugs and Biological Products; Draft Guidance for Industry; Availability

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSNOTICE — NO LEGAL EFFECT
EFFECTIVE—
COMMENTS CLOSEOct 13, 2026 · closed
APPLIES TO · SPEQ TAGDrugBiologicsDevice
Document type
Notice
Agency
Health and Human Services Department
Published
August 14, 2026
Comments close
October 13, 2026
Document number
2026-16638
Docket
FDA-2026-D-7957
ABSTRACT

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry entitled "Container Closure Systems for Human Drugs and Biological Products." This document provides guiding principles for evaluating the quality of container closure systems (CCSs) used to package drugs and biological products, for human use. This includes CCSs that are also device constituent parts of combination products and CCSs used to package the drug or biological product constituent parts of combination products.

Abstract as published in the Federal Register.

READ THE FULL DOCUMENT

The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.

View on federalregister.gov →

That is what FDA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.

Create a free account